Targeting molecular resistance in castration-resistant prostate cancer

BMC Medicine
Thenappan ChandrasekarChristopher P Evans

Abstract

Multiple mechanisms of resistance contribute to the inevitable progression of hormone-sensitive prostate cancer to castration-resistant prostate cancer (CRPC). Currently approved therapies for CRPC include systemic chemotherapy (docetaxel and cabazitaxel) and agents targeting the resistance pathways leading to CRPC, including enzalutamide and abiraterone. While there is significant survival benefit, primary and secondary resistance to these therapies develops rapidly. Up to one-third of patients have primary resistance to enzalutamide and abiraterone; the remaining patients eventually progress on treatment. Understanding the mechanisms of resistance resulting in progression as well as identifying new targetable pathways remains the focus of current prostate cancer research. We review current knowledge of mechanisms of resistance to the currently approved treatments, development of adjunctive therapies, and identification of new pathways being targeted for therapeutic purposes.

References

Mar 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·M L ShelanskiC R Cantor
Jan 1, 1994·Vitamins and Hormones·J LindzeyD J Tindall
Feb 9, 1999·Vitamins and Hormones·A K RoyB Chatterjee
Dec 2, 2000·Science·D J Klionsky, S D Emr
Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·J S SackH M Einspahr
Feb 21, 2002·Trends in Endocrinology and Metabolism : TEM·Ola HermansonMichael G Rosenfeld
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward P Gelmann
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Karine SteketeeJan Trapman
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Urs E StuderDaniel Dietrich
Jul 30, 2005·Journal of Cellular Biochemistry·Kwanchanit TantivejkulKenneth J Pienta
Aug 23, 2005·Nature Cell Biology·Honglai ZhangCun-Yu Wang
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Josep Domingo-DomenechBegoña Mellado
Mar 16, 2007·Neoplasia : an International Journal for Oncology Research·Yu-Ming ChangChristopher P Evans
Oct 3, 2007·Nature Cell Biology·Zhiping Xie, Daniel J Klionsky
Dec 11, 2007·Biochimica Et Biophysica Acta·Barbara T McGroganAmanda McCann
Feb 29, 2008·Nature·Noboru MizushimaDaniel J Klionsky
Apr 9, 2008·Journal of Cellular Biochemistry·Irene M WolfDonald B DeFranco
May 24, 2008·Advances in Experimental Medicine and Biology·Irina U Agoulnik, Nancy L Weigel
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tristan M SissungWilliam D Figg
Aug 2, 2008·Neoplasia : an International Journal for Oncology Research·Wennuan LiuJianfeng Xu
Feb 10, 2009·Nature Clinical Practice. Urology·William P HarrisBruce Montgomery
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhardt AttardJohann S de Bono
Jul 30, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jae Yeon ChunAllen C Gao
Nov 26, 2009·The International Journal of Biochemistry & Cell Biology·Nigel C BennettGlenda C Gobe
Dec 17, 2009·The Journal of Biological Chemistry·Dennis J van de WijngaartHendrikus J Dubbink
Mar 23, 2010·Molecular Endocrinology·Sarah DenayerFrank Claessens
May 27, 2010·Molecular Cancer Therapeutics·Bin ZhongJulie Y Djeu
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Jul 21, 2010·The Journal of Clinical Investigation·Shihua SunStephen R Plymate
Aug 17, 2010·Asian Journal of Andrology·Shahriar Koochekpour

❮ Previous
Next ❯

Citations

Aug 10, 2016·Targeted Oncology·Cara M StatzSusan M Mockus
Oct 30, 2016·Cancer Medicine·Sanghoon LeeJu-Hong Jeon
Sep 6, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Chi-Ming LiuChung-Yi Chen
Nov 16, 2017·Expert Opinion on Drug Metabolism & Toxicology·Charles F PolottiSammy Elsamra
Mar 12, 2019·Cancer Biotherapy & Radiopharmaceuticals·Xiaokun MaXiangyuan Wu
Jul 30, 2019·Expert Opinion on Drug Safety·Pietro CastellanLuca Cindolo
Apr 5, 2018·Oncology Letters·Yiqiao HuangGanggang Jiang
Sep 8, 2017·Nuclear Medicine and Molecular Imaging·Martin K BakhtKeon Wook Kang
Jun 9, 2020·Expert Review of Anticancer Therapy·Ruby GuptaJorge A Garcia
Mar 19, 2019·Asian Journal of Andrology·Octavio Orellana-SerradellHéctor R Contreras
Aug 18, 2018·Prostate Cancer and Prostatic Diseases·Sigfred Ian R AlpajaroChristopher P Evans
Jul 13, 2017·Molecular Cancer Therapeutics·Alan P LombardAllen C Gao
Sep 25, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Iris Sze Ue LukYuzhuo Wang
Dec 2, 2020·The Prostate·Jennifer R HertzogTheresa M McDevitt
Jan 10, 2021·International Journal of Molecular Sciences·Subrata DebEmma S Tomlinson Guns
Aug 3, 2016·The Journal of Steroid Biochemistry and Molecular Biology·Senthilmurugan RamalingamVincent C O Njar

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
xenograft
ChIP-seq

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis